| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; loading ...; fig 6b
- western blot; human; loading ...; fig 6a
| Yan M, Wang J, Ren Y, Li L, He W, Zhang Y, et al. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death Dis. 2019;10:204 pubmed publisher |
- western blot; human; loading ...; fig s3e
| Göllner S, Oellerich T, Agrawal Singh S, Schenk T, Klein H, Rohde C, et al. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. Nat Med. 2017;23:69-78 pubmed publisher |
- western blot; human; loading ...; fig 2a
| Torres A, Vargas Y, Uribe D, Jaramillo C, Gleisner A, Salazar Onfray F, et al. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget. 2016;7:67373-67386 pubmed publisher |
- western blot; human; fig 4
| Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, et al. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco Targets Ther. 2016;9:3501-9 pubmed publisher |
- immunohistochemistry; human; 1:50; fig 1
| Kim B, Stephen S, Hanby A, Horgan K, Perry S, Richardson J, et al. Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer. 2015;15:634 pubmed publisher |
- western blot; human; 1:200
| Zhang H, Patel A, Ma S, Li X, Zhang Y, Yang P, et al. In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. Br J Pharmacol. 2014;171:5845-57 pubmed publisher |
| Afrouzian M, Al Lahham R, Patrikeeva S, Xu M, Fokina V, Fischer W, et al. Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin. Biochem Pharmacol. 2018;156:467-478 pubmed publisher |
| Torres A, Arriagada V, Erices J, Toro M, Rocha J, Niechi I, et al. FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells. Int J Mol Sci. 2018;19: pubmed publisher |
| Kim B, Fatayer H, Hanby A, Horgan K, Perry S, Valleley E, et al. Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer. PLoS ONE. 2013;8:e62766 pubmed publisher |
| Markó L, Paragh G, Ugocsai P, Boettcher A, Vogt T, Schling P, et al. Keratinocyte ATP binding cassette transporter expression is regulated by ultraviolet light. J Photochem Photobiol B. 2012;116:79-88 pubmed publisher |
| Shi Z, Yang W, Chen L, Yang D, Zhou Q, Zhu J, et al. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Res Treat. 2012;135:737-47 pubmed publisher |
| Quezada C, Garrido W, Oyarzun C, Fernandez K, Segura R, Melo R, et al. 5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells. J Cell Physiol. 2013;228:602-8 pubmed publisher |
| Villar V, Vögler O, Martínez Serra J, Ramos R, Calabuig Fariñas S, Gutierrez A, et al. Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomas. PLoS ONE. 2012;7:e37735 pubmed publisher |
| Cheng C, Liu Z, Zhang H, Xie J, Chen X, Zhao X, et al. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202. Mol Pharm. 2012;9:1971-82 pubmed publisher |
| Garrido W, Munoz M, San Martin R, Quezada C. FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1. Biochem Biophys Res Commun. 2011;411:62-8 pubmed publisher |
| Peigñan L, Garrido W, Segura R, Melo R, Rojas D, Cárcamo J, et al. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro. Neurochem Res. 2011;36:1397-406 pubmed publisher |
| Mi Y, Liang Y, Huang H, Zhao H, Wu C, Wang F, et al. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Res. 2010;70:7981-91 pubmed publisher |
| Imesch P, Fink D, Fedier A. Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril. 2010;94:2838-42 pubmed publisher |
| Imesch P, Dedes K, Furlato M, Fink D, Fedier A. MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. Int J Oncol. 2009;35:631-40 pubmed |
| Vanpouille C, Le Jeune N, Kryza D, Clotagatide A, Janier M, Dubois F, et al. Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model. Eur J Nucl Med Mol Imaging. 2009;36:1256-64 pubmed publisher |
